×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
ESMO Asia Congress 2019
Final Programme PDF
Advanced Search
22.11.2019
23.11.2019
24.11.2019
Challenge Your Expert session
Collaborative session
ESMO Colloquium
Educational session
Industry Satellite Symposium
Mini Oral session
Multidisciplinary tumour board
Opening session
Proffered Paper session
Special Session
Young Oncologist session
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
Hall 406
09:45(1h 40m)
Opening Ceremony
14:30(1h 30m)
Proffered paper session - Thoracic cancers
Hall 405
12:45(1h 30m)
AstraZeneca - Changing the course for the lung cancer patient: A new direction
14:30(1h 30m)
Integrating new treatment paradigms in breast cancer care in 2019
16:30(1h 30m)
Precision immunotherapy
Hall 404
12:45(1h 30m)
AstraZeneca - PARP inhibitors as targeted therapy for personalised medicine
14:30(1h 30m)
Contemporary issues in cervical cancer management
16:30(1h 30m)
Mixed Proffered paper session - Gastrointestinal tumours & Head and neck cancers
11:45(45m)
Optimal sequence and treatment choice in osimertinib failure
Hall 407
12:45(1h 30m)
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
14:30(1h 30m)
Precision medicine in advanced gastrointestinal cancer
11:45(45m)
Surgical management of ovarian cancer
16:30(1h 30m)
Tumour agnostic drug development
Summit 2
11:45(45m)
Immunotherapy in GU cancers: Focus on kidney and bladder cancers
14:30(50m)
Mini Oral session - Genitourinary tumours
12:45(1h 30m)
Roche - Precision oncology in Asia: A new dawn or a false hope?
16:30(1h 30m)
The multi-modality approach to sarcomas: Balancing cure and quality of life
Room 326
14:30(1h 30m)
Improving cancer care in Asia
16:30(1h)
Mini Oral session - Supportive and palliative care
Exhibition area
16:00(30m)
Meet your mentor
Room 311
16:30(1h 30m)
Biosimilars use in oncology: Clarifying concepts
15:00(1h)
Mini Oral session - Developmental and precision medicine
11:40(40m)
Mini Oral session - Sarcoma
12:45(1h 30m)
MSD - A quantum leap in treatment of NSCLC and HNSCC with IO
Room 324
16:30(1h 30m)
ESMO – CSCO Collaborative Session: Drug prioritisation and support of biomarkers
14:30(1h 30m)
ESMO – JSMO Collaborative Session: Guideline harmonisations and international consensus
11:45(45m)
Locally advanced nasopharyngeal carcinoma (LA NPC): Asian and European perspectives
12:45(1h 30m)
Pfizer - From clinical trials to practice: Changing the trajectory for metastatic breast cancer patients
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events